Targeting the αv integrin/TGF-β axis improves natural killer cell function against glioblastoma stem cells.
J Clin Invest. 2021 Jul 15;131(14):e142116. doi: 10.1172/JCI142116.
J Clin Invest. 2021.
PMID: 34138753
Free PMC article.